First international symposium of current issues for nationwide survey of primary liver cancer in Korea, Taiwan and Japan

Japanese Journal of Clinical Oncology

Volumn 37, Issue 3, 2007, Pages 233-240

  Takayasu, Kenichi ^a   Choi, Byung Ihn ^b   Wang, Chung Kwe ^c,g   Ikai, Iwao ^d   Okita, Kiwamu ^e   Chen, Ran Chou ^c,g   Lo, Hoi Wan ^f,g   Chen, Pao Huei ^f,g  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Seoul National University Hospital   (South Korea)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d KYOTO UNIVERSITY   (Japan)

^e Social Insurance Alliance Shimonoseki Kohsei Hospital   (Japan)

^f YUAN'S GENERAL HOSPITAL   (Taiwan)

^g The Liver Cancer Study Group of Taiwan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANGIOGENESIS INHIBITOR; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GELATIN SPONGE; HEPATITIS B VACCINE; IODINATED POPPYSEED OIL;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RESEARCH; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC IMAGING; EPIDEMIOLOGICAL DATA; HEPATITIS B; HUMAN; JAPAN; KOREA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER SURGERY; LIVER TRANSPLANTATION; MASS IMMUNIZATION; MICROWAVE THERAPY; MONOTHERAPY; PORTAL VEIN THROMBOSIS; PRACTICE GUIDELINE; PROGNOSIS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; SYMPOSIUM; TAIWAN; VACCINATION;

DATA COLLECTION; HUMANS; JAPAN; KOREA; LIVER NEOPLASMS; TAIWAN;

EID: 34447633057     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym012     Document Type: Conference Paper

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
2. Wang HJ. Cancer registry for primary liver cancer. Korean J HBP Surgery 2004;8:207-16.
3. Wang HJ. Proceedings of Ninth Annual Convention of the Korean Liver Cancer Study Group 2006; 19-22.
4. Park JW, Kim CM. Epidemiology of hepatocellular carcinoma in Korea. Korean J Hepatol 2005;11:303-10.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
6. Han KH, Park JW. The usefulness and current status of the screening program for early diagnosis of hepatocellular carcinoma. J Korean Med Assoc 2002;45:972-80.
7. Choi BI. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl 2004;10:S20-25.
8. Koh KC. Recent trend of therapy for HCC: Evidence-based approach. Proceedings of Ninth Annual Convention of the Korean Liver Cancer Study Group 2006; 39-48.
9. Lee SG. Current status of liver transplantation in Korea. Korean J Gastroenterol 2005;46:75-83.
10. Park JH, Chung JW, Lee SK. Chemoembolization of hepatocellular carcinoma: Long-term survival and prognostic factors. J Korean Radiol Soc 1996;35:315-25
11. Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. In: Korean Liver Cancer Study Group, editors. The General Rules for the Study of Primary Liver Cancer, 2nd edn. Seoul: Sung Man Gak, 2004: 57-70.
12. Chen PH, Wang CS, Wang CK, Liaw LY, Chen RC, Lo HY. Hepatocellular carcinoma in Taiwan. Proceeding of the 33rd Annual Meeting of Liver Cancer Study Group of Japan, 1997: 42-3.
13. Chen PH, Lo HW, Wang CS, Tsai KR, Chen YC, Lin KY, et al. Cholangiocarcinoma in hepatolithiasis. J Clin Gastroenterol 1984;6:539-47.
14. Li YH, Wang CS, Liao LY, Wang CK, Shih LS, Chen RC, et al. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection. J Formos Med Assoc 2003;102:141-6.
15. Wang CS, Lin CL, Lee HC, Chen KY, Chiang MF, Chen HS, et al. Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol 2005;11:6115-9.
16. Ho MC, Wu YM, Hu RH, Ko WJ, Yang PM, Lai MY, et al. Liver transplantation for patients with hepatocellular carcinoma. Transplant Proc 2004;36:2291-2.
17. Chen CL, Fan ST, Lee SG, Makuuchi M, Tanaka K. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 2003;75:S6-11.
18. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127:1714-23.
19. Huang YH, Chen CH, Chang TT, Chen SC, Chiang JH, Lee HS, et al. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: A nationwide, multicentre study evaluated by cancer stage. Aliment Pharmacol Ther 2005;21:687-94.
20. Cheng JC, Wu JK, Huang CM, Liu HS, Huang DY, Tsai SY, et al. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2003;56:229-34.
21. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
22. Kudo M, Arii S, Ikai I, Okazaki M, Okita K, Omata M, et al. Report of the 17th Follow-up Survey of Primary Liver Cancer. Kyoto: Media Planning 2006 (in Japanease).
23. Okuda K, The Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980;45:2663-9.
24. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1984;54:1747-55.
25. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Sixth Report. Cancer 1987;60:1400-11.
26. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
27. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-80.
28. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-9.
29. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004;101:796-802.
30. Ikai I, Arii S, Ichida T, Okita K, Omata M, Kojiro M, et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 2005;32:163-72.
31. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-9.
32. Ikai I, Takayasu K, Omata M, Okita K, Nakanuma Y, Matsuyama Y, et al. A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma. J Gastroenterol 2006;41:884-92.
33. The Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd Engl. edn. Tokyo: Kanehara 2003.